Delving into the Latest Updates on Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Hemic and Lymphatic Diseases

Colony-stimulating factors

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	1

Top 5 Drug Type	Count

Colony-stimulating factors	1

Top 5 Target	Count

EPO receptor(Erythropoietin receptor)	1

In patients with stable chronic renal failure receiving HD treatment, a control comparison was performed to verify that the safety and anemia-improving effect of darbepoietin α injection were not inferior to recombinant human erythropoietin when the target Hb concentration (10.0 g/dL ≦ Hb concentration ≦ 12.0 g/dL) was reached.

Start Date01 Jul 2013

Sponsor / Collaborator

Terumo Corp.

[+2]

CTR20130080

/ CompletedPhase 3

以重组人促红素注射液为对照的达依泊汀α注射液治疗慢性肾功能衰竭血液透析患者贫血的非劣效性试验

[Translation] A non-inferiority trial of darbepoietin α injection compared with recombinant human erythropoietin injection in the treatment of anemia in hemodialysis patients with chronic renal failure

以HD患者中未接受过ESA给药的患者为对象，通过对照比较，验证达到目标Hb浓度（10.0 g/dL≦Hb浓度≦12.0 g/dL）时达依泊汀α注射液的安全性及贫血改善效果不劣于重组人促红素。

[Translation]

Through control comparison, we used HD patients who had not received ESA administration as the subjects to verify that the safety and anemia improvement effect of darbepoietin α injection were not inferior to recombinant human erythropoietin when the target Hb concentration (10.0 g/dL ≦ Hb concentration ≦ 12.0 g/dL) was reached.

Start Date22 Apr 2013

Sponsor / Collaborator

Terumo Corp.

[+2]

100 Clinical Results associated with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Oct 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data